MRFRの分析によると、血液代用剤の市場規模は2022年に1.76(10億ドル)と推定されました。この市場は、2023 年の 1.9 (10 億ドル) から 2032 年までに 3.8 (10 億ドル) に成長すると予想され、予測期間中（2024-2032）のCAGRは約7.98%になる見込みです。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY TYPE (USD BILLION)
6.1. Hemoglobin-Based Blood Substitutes
6.2. Perfluorocarbon-Based Blood Substitutes
6.3. Oxygen Carrier-Based Blood Substitutes
7. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION (USD BILLION)
7.1. Emergency Medical Care
7.2. Trauma Management
7.3. Surgery
7.4. Transfusion Medicine
8. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END-USER (USD BILLION)
8.1. Hospitals
8.2. Military
8.3. Pre-Hospital Care Providers
9. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGIONAL (USD BILLION)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Russia
9.2.5. Italy
9.2.6. Spain
9.2.7. Rest of Europe
9.3. APAC
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Malaysia
9.3.6. Thailand
9.3.7. Indonesia
9.3.8. Rest of APAC
9.4. South America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.4.4. Rest of South America
9.5. MEA
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of MEA
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market share Analysis
10.4. Major Growth Strategy in the Artificial Blood Substitutes Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Artificial Blood Substitutes Market
10.7. Key developments and growth strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales and Operating Income
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. HemCon Medical Technologies Inc.
11.1.1. Financial Overview
11.1.2. Products Offered
11.1.3. Key Developments
11.1.4. SWOT Analysis
11.1.5. Key Strategies
11.2. Matrox Medical, Inc.
11.2.1. Financial Overview
11.2.2. Products Offered
11.2.3. Key Developments
11.2.4. SWOT Analysis
11.2.5. Key Strategies
11.3. Sorrento Therapeutics, Inc.
11.3.1. Financial Overview
11.3.2. Products Offered
11.3.3. Key Developments
11.3.4. SWOT Analysis
11.3.5. Key Strategies
11.4. Xeris Pharmaceuticals, Inc.
11.4.1. Financial Overview
11.4.2. Products Offered
11.4.3. Key Developments
11.4.4. SWOT Analysis
11.4.5. Key Strategies
11.5. BPL Medical Technologies
11.5.1. Financial Overview
11.5.2. Products Offered
11.5.3. Key Developments
11.5.4. SWOT Analysis
11.5.5. Key Strategies
11.6. Hemarina AB
11.6.1. Financial Overview
11.6.2. Products Offered
11.6.3. Key Developments
11.6.4. SWOT Analysis
11.6.5. Key Strategies
11.7. Sangart Inc.
11.7.1. Financial Overview
11.7.2. Products Offered
11.7.3. Key Developments
11.7.4. SWOT Analysis
11.7.5. Key Strategies
11.8. Hemosol Inc.
11.8.1. Financial Overview
11.8.2. Products Offered
11.8.3. Key Developments
11.8.4. SWOT Analysis
11.8.5. Key Strategies
11.9. Sonaca Group
11.9.1. Financial Overview
11.9.2. Products Offered
11.9.3. Key Developments
11.9.4. SWOT Analysis
11.9.5. Key Strategies
11.10. The Medicines Company
11.10.1. Financial Overview
11.10.2. Products Offered
11.10.3. Key Developments
11.10.4. SWOT Analysis
11.10.5. Key Strategies
11.11. Erytech Pharma
11.11.1. Financial Overview
11.11.2. Products Offered
11.11.3. Key Developments
11.11.4. SWOT Analysis
11.11.5. Key Strategies
11.12. American Red Cross
11.12.1. Financial Overview
11.12.2. Products Offered
11.12.3. Key Developments
11.12.4. SWOT Analysis
11.12.5. Key Strategies
11.13. Baxter International Inc.
11.13.1. Financial Overview
11.13.2. Products Offered
11.13.3. Key Developments
11.13.4. SWOT Analysis
11.13.5. Key Strategies
11.14. Hemerus Medical B.V.
11.14.1. Financial Overview
11.14.2. Products Offered
11.14.3. Key Developments
11.14.4. SWOT Analysis
11.14.5. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 6. US ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 7. US ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 8. US ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 9. US ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 10. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 11. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 16. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 18. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 19. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 20. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 21. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 24. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 25. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 27. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 28. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 29. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 30. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 31. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 32. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 33. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 34. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 35. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 36. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 37. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 40. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 41. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 44. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 45. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 46. APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 47. APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 48. APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 49. APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 52. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 53. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 54. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 55. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 56. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 57. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 58. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 59. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 60. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 61. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 64. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 65. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 66. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 67. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 68. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 69. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 70. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 71. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 72. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 73. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 76. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 77. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 78. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 79. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 80. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 81. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 84. SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 85. SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 87. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 88. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 89. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 90. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 91. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 92. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 93. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 94. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 95. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 96. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 97. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 104. MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 105. MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 106. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 107. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 108. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 109. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 112. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 113. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 114. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 115. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 118. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 119. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS
FIGURE 3. US ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 4. US ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 5. US ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 6. US ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 7. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 8. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 9. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 10. CANADA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 11. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS
FIGURE 12. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 13. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 14. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 15. GERMANY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 16. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 17. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 18. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 19. UK ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 20. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 21. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 22. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 23. FRANCE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 24. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 25. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 26. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 27. RUSSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 28. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 29. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 30. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 31. ITALY ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 32. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 33. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 34. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 35. SPAIN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 36. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 37. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 38. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 39. REST OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 40. APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS
FIGURE 41. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 42. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 43. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 44. CHINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 45. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 46. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 47. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 48. INDIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 49. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 50. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 51. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 52. JAPAN ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 53. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 54. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 55. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 56. SOUTH KOREA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 57. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 58. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 59. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 60. MALAYSIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 61. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 62. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 63. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 64. THAILAND ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 66. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 67. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 68. INDONESIA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 69. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 70. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 71. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 72. REST OF APAC ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 73. SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS
FIGURE 74. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 75. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 76. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 77. BRAZIL ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 78. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 79. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 80. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 81. MEXICO ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 82. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 83. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 84. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 85. ARGENTINA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 86. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 87. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 88. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 89. REST OF SOUTH AMERICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 90. MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS
FIGURE 91. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 92. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 93. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 94. GCC COUNTRIES ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 95. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 96. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 97. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 98. SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 99. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY TYPE
FIGURE 100. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY APPLICATION
FIGURE 101. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY END-USER
FIGURE 102. REST OF MEA ARTIFICIAL BLOOD SUBSTITUTES MARKET ANALYSIS BY REGIONAL
FIGURE 103. KEY BUYING CRITERIA OF ARTIFICIAL BLOOD SUBSTITUTES MARKET
FIGURE 104. RESEARCH PROCESS OF MRFR
FIGURE 105. DRO ANALYSIS OF ARTIFICIAL BLOOD SUBSTITUTES MARKET
FIGURE 106. DRIVERS IMPACT ANALYSIS: ARTIFICIAL BLOOD SUBSTITUTES MARKET
FIGURE 107. RESTRAINTS IMPACT ANALYSIS: ARTIFICIAL BLOOD SUBSTITUTES MARKET
FIGURE 108. SUPPLY / VALUE CHAIN: ARTIFICIAL BLOOD SUBSTITUTES MARKET
FIGURE 109. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 110. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY TYPE, 2019 TO 2032 (USD Billions)
FIGURE 111. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 112. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 113. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END-USER, 2024 (% SHARE)
FIGURE 114. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END-USER, 2019 TO 2032 (USD Billions)
FIGURE 115. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 116. ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 117. BENCHMARKING OF MAJOR COMPETITORS
